TCTAP 2022

Cost-Effectiveness Analysis of High-Potency Versus Low-Potency Statins for Reducing Mortality in Coronary Artery Disease Patients on Dual Antiplatelet Therapy Post Percutaneous Coronary Intervention.

- Presenter : Shaban Mohammed

Leave a comment

Sign in to leave a comment.